These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 2040357)

  • 1. Alterations in dopamine release from striatal slices of rats after chronic treatment with haloperidol.
    Yamada S; Yokoo H; Harajiri S; Nishi S
    Eur J Pharmacol; 1991 Jan; 192(1):141-5. PubMed ID: 2040357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic treatment with haloperidol modifies the sensitivity of autoreceptors that modulate dopamine release in rat striatum.
    Yamada S; Yokoo H; Nishi S
    Eur J Pharmacol; 1993 Feb; 232(1):1-6. PubMed ID: 8458389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decrease in the evoked release of endogenous dopamine and dihydroxyphenylacetic acid from rat striatal slices after withdrawal from repeated haloperidol.
    Umeda Y; Sumi T
    Eur J Pharmacol; 1990 Nov; 191(2):149-55. PubMed ID: 2086236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Regulation of (-)-sulpiride-induced increase in evoked dopamine release from striatal slices in rat].
    Yamada S; Yokoo H; Nishi S
    Yakubutsu Seishin Kodo; 1992 Aug; 12(4):193-7. PubMed ID: 1414037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inhibitory effect of haloperidol on evoked dopamine release from striatal slices of the rat].
    Yamada S; Takaki T; Yokoo H; Tanaka M
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1995 Feb; 15(1):43-52. PubMed ID: 7750016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in sensitivity of dopamine autoreceptors in rat striatum after subchronic treatment with methamphetamine.
    Yamada S; Yokoo H; Nishi S
    Eur J Pharmacol; 1991 Nov; 205(1):43-7. PubMed ID: 1811995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of acute and chronic clozapine and haloperidol on in vitro release of acetylcholine and dopamine from striatum and nucleus accumbens.
    Compton DR; Johnson KM
    J Pharmacol Exp Ther; 1989 Feb; 248(2):521-30. PubMed ID: 2918468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in sensitivity of release modulating dopamine autoreceptors after chronic treatment with haloperidol.
    Nowak JZ; Arbilla S; Galzin AM; Langer SZ
    J Pharmacol Exp Ther; 1983 Aug; 226(2):558-64. PubMed ID: 6875865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of neuroleptics on release of 3H-dopamine from slices of rat corpus striatum.
    Dismukes K; Mulder AH
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Mar; 297(1):23-9. PubMed ID: 16224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of the endogenous acetylcholine release from rat striatal slices.
    Alberch J; Marsal J; Solsona C
    Brain Res; 1985 Nov; 346(2):353-6. PubMed ID: 2996707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-related decrements in the muscarinic enhancement of K+-evoked release of endogenous striatal dopamine: an indicator of altered cholinergic-dopaminergic reciprocal inhibitory control in senescence.
    Joseph JA; Dalton TK; Hunt WA
    Brain Res; 1988 Jun; 454(1-2):140-8. PubMed ID: 2900662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of SCH 39166, a novel dopamine D1 receptor antagonist, on [3H]acetylcholine release in rat striatal slices.
    Tedford CE; Crosby G; Iorio LC; Chipkin RE
    Eur J Pharmacol; 1992 Feb; 211(2):169-76. PubMed ID: 1535318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of the stereoisomers of 3PPP on dopaminergic and cholinergic neurotransmission in superfused slices of the corpus striatum.
    Arbilla S; Langer SZ
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Aug; 327(1):6-13. PubMed ID: 6092969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of (-)-sulpiride-induced increase in electrically-evoked release of dopamine from rat striatal slices.
    Yamada S; Yokoo H; Nishi S
    J Pharm Pharmacol; 1993 May; 45(5):479-81. PubMed ID: 8099971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apomorphine does not reverse reduced basal dopamine release in rat striatum and nucleus accumbens after chronic haloperidol treatment.
    Ichikawa J; Meltzer HY
    Brain Res; 1990 Jan; 507(1):138-42. PubMed ID: 2302571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presynaptic inhibitory dopamine receptors on noradrenergic nerve terminals: analysis of biphasic actions of dopamine and apomorphine on the release of endogenous norepinephrine in rat hypothalamic slices.
    Misu Y; Goshima Y; Ueda H; Kubo T
    J Pharmacol Exp Ther; 1985 Dec; 235(3):771-7. PubMed ID: 3001276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apomorphine and haloperidol effects on striatal 3H-dopamine release in anesthetized, awake restrained and freely moving rats.
    Spampinato U; Girault JA; Danguir J; Savaki HE; Glowinski J; Besson MJ
    Brain Res Bull; 1986 Feb; 16(2):161-6. PubMed ID: 3697784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of the cholinergic system in haloperidol-induced release of dopamine from slices of striatum in the rat.
    Yamada S; Nishi S; Kojima H; Yokoo H; Tsutsumi T; Inanaga K
    Neuropharmacology; 1990 Jan; 29(1):55-9. PubMed ID: 2304616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency-dependent release of acetylcholine and dopamine from rabbit striatum: its modulation by dopaminergic receptors.
    Cubeddu LX; Hoffmann IS
    J Neurochem; 1983 Jul; 41(1):94-101. PubMed ID: 6864232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic haloperidol decreases dopamine release in striatum and nucleus accumbens in vivo: depolarization block as a possible mechanism of action.
    Lane RF; Blaha CD
    Brain Res Bull; 1987 Jan; 18(1):135-8. PubMed ID: 3828839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.